MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

FATE THERAPEUTICS INC (FATE)

FATE THERAPEUTICS INC (FATE)

|||

Balance Sheets Overview

Current Ratio
484.64%
Quick Ratio
484.64%
Cash Ratio
99.50%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Property and equipment, net
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
32,429
39,570
46,628
40,622
Accounts receivable
703
704
916
682
Short-term investments
121,341
135,252
157,029
174,801
Prepaid expenses and other current assets
3,480
4,000
4,131
5,146
Total current assets
157,953
179,526
208,704
221,251
Long-term investments
0
0
1,472
10,305
Property and equipment, gross
-
-
93,148
-
Less accumulated depreciation and amortization
-
-
36,223
-
Property and equipment, net
51,546
54,262
56,925
59,475
Operating lease right-of-use assets
40,554
41,078
41,609
42,413
Restricted cash
10,050
10,050
10,227
10,227
Other assets
-
-
0
0
Total assets
260,103
284,916
318,937
343,671
Accounts payable
3,258
3,277
2,656
3,504
Accrued expenses
14,904
13,642
20,024
17,571
Cirm award liability, current portion
9,508
8,448
8,448
2,280
Deferred revenue
0
582
381
5
Operating lease liabilities, current portion
4,922
4,740
4,562
4,751
Total current liabilities
32,592
30,689
36,071
28,111
Cirm award liability, net of current portion
2,377
2,112
2,112
6,590
Operating lease liabilities, net of current portion
70,753
72,045
73,287
74,494
Stock price appreciation milestones
943
363
283
410
Preferred stock, 0.001 par value authorized shares - 5,000,000 class a convertible preferred shares issued and outstanding - 2,755,086 at june 30, 2026 and december 31, 2025
3
3
3
3
Common stock, 0.001 par value authorized shares-350,000,000 issued and outstanding-116,694,106 at june 30, 2026 and 115,359,735 at december 31,2025
117
116
115
115
Additional paid-in capital
1,749,116
1,745,187
1,741,259
1,735,730
Accumulated other comprehensive income (loss)
-117
-77
116
153
Accumulated deficit
-1,595,681
-1,565,522
-1,534,309
-1,501,935
Total stockholders equity
153,438
179,707
207,184
234,066
Total liabilities and stockholders equity
260,103
284,916
318,937
343,671
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$121,341K (-33.18%↓ Y/Y)Cash and cashequivalents$32,429K (-21.38%↓ Y/Y)Prepaid expenses andother current assets$3,480K (-43.62%↓ Y/Y)Accounts receivable$703K (-49.61%↓ Y/Y)Total current assets$157,953K (-31.44%↓ Y/Y)Property and equipment,net$51,546K (-15.63%↓ Y/Y)Operating leaseright-of-use assets$40,554K (-7.44%↓ Y/Y)Restricted cash$10,050K (-1.73%↓ Y/Y)Total assets$260,103K (-30.01%↓ Y/Y)Total liabilities andstockholders equity$260,103K (-30.01%↓ Y/Y)Total stockholdersequity$153,438K (-41.29%↓ Y/Y)Operating leaseliabilities, net of current...$70,753K (-6.50%↓ Y/Y)Total currentliabilities$32,592K (13.67%↑ Y/Y)Cirm awardliability, net of current...$2,377K (-57.55%↓ Y/Y)Stock priceappreciation milestones$943K (194.69%↑ Y/Y)Accumulated deficit-$1,595,681K (-8.57%↓ Y/Y)Accumulated othercomprehensive income (loss)-$117K (-288.71%↓ Y/Y)Additional paid-in capital$1,749,116K (1.05%↑ Y/Y)Accrued expenses$14,904K (-18.03%↓ Y/Y)Cirm awardliability, current portion$9,508K (1095.97%↑ Y/Y)Operating leaseliabilities, current portion$4,922K (-12.98%↓ Y/Y)Accounts payable$3,258K (-19.36%↓ Y/Y)Common stock, 0.001 parvalue authorized...$117K (1.74%↑ Y/Y)Preferred stock, 0.001 parvalue authorized...$3K (0.00%↑ Y/Y)